ProQR Therapeutics BV (PRQR) — Free Cash Flow Generation Index

Latest as of March 2023: 1.00x

ProQR Therapeutics BV (PRQR) has a Free Cash Flow Generation Index of 1.00x as of March 2023. Free cash flow of $44.59 Million represents 1% of operating cash flow ($44.73 Million). Explore reinvestment intensity of ProQR Therapeutics BV to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$44.59 Million
USD

Operating Cash Flow

$44.73 Million
USD

Capital Expenditures

$136.00K
USD

ProQR Therapeutics BV Free Cash Flow Generation Index (2023–2023)

Historical FCF Generation Index trend for ProQR Therapeutics BV across 1 annual periods. For the full cash flow conversion analysis, see ProQR Therapeutics BV cash flow conversion.

Annual Free Cash Flow Generation for ProQR Therapeutics BV (2023–2023)

Year-by-year Free Cash Flow Generation Index for ProQR Therapeutics BV. Check PRQR cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2023 0.94x $20.18 Million $21.55 Million $1.37 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).